These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38565861)

  • 1. The antihyperglycemic potential of pyrazolobenzothiazine 1, 1-dioxide novel derivative in mice using integrated molecular pharmacological approach.
    Taj S; Ashfaq UA; Ahmad M; Noor H; Ikram A; Ahmed R; Tariq M; Masoud MS; Hasan A
    Sci Rep; 2024 Apr; 14(1):7746. PubMed ID: 38565861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring of novel 4-hydroxy-2H-benzo[e][1,2]thiazine-3-carbohydrazide 1,1-dioxide derivative as a dual inhibitor of α-glucosidase and α-amylase: Molecular docking, biochemical, enzyme kinetic and in-vivo mouse model study.
    Taj S; Ahmad M; Ashfaq UA
    Int J Biol Macromol; 2022 May; 207():507-521. PubMed ID: 35276296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation.
    Khamees Thabet H; Ammar YA; Imran M; Hamdy Helal M; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Abusaif MS; Ragab A
    Bioorg Chem; 2024 Oct; 151():107671. PubMed ID: 39067419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent.
    Rashid F; Ahmad M; Ashfaq UA; Al-Mutairi AA; Al-Hussain SA
    Drug Des Devel Ther; 2022; 16():4043-4060. PubMed ID: 36444273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
    Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM
    Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cinnamic acid magnolol derivatives as potent α-glucosidase and α-amylase inhibitors: Synthesis, in vitro and in silico studies.
    Hu CM; Wang WJ; Ye YN; Kang Y; Lin J; Wu PP; Li DL; Bai LP; Xu XT; Li BQ; Zhang K
    Bioorg Chem; 2021 Nov; 116():105291. PubMed ID: 34438122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting
    Gohar NA; Fayed EA; A Ammar Y; A Abu Ali O; Ragab A; Mahfoz AM; Abusaif MS
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2367128. PubMed ID: 38913598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of Diosmin to Control Diabetes and Its Complications-an In Vitro and In Silico Approach.
    Dubey K; Dubey R; Gupta R; Gupta A
    Curr Comput Aided Drug Des; 2021; 17(2):307-313. PubMed ID: 32208122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regioselective syntheses of 2-oxopyridine carbonitrile derivatives and evaluation for antihyperglycemic and antioxidant potential.
    Saleem F; Haider M; Khan KM; Özil M; Baltaş N; Ul-Haq Z; Qureshi U; Salar U; Taha M; Hameed S; Ullah N
    Int J Biol Macromol; 2023 Jun; 241():124589. PubMed ID: 37116840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feruloyl Sucrose Esters: Potent and Selective Inhibitors of α-glucosidase and α-amylase.
    Devaraj S; Yip YM; Panda P; Ong LL; Wong PWK; Zhang D; Ali Y; Judeh Z
    Curr Med Chem; 2022; 29(9):1606-1621. PubMed ID: 34455958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies.
    Saleem F; Kanwal ; Khan KM; Chigurupati S; Solangi M; Nemala AR; Mushtaq M; Ul-Haq Z; Taha M; Perveen S
    Bioorg Chem; 2021 Jan; 106():104489. PubMed ID: 33272713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of α-glucosidase and α-amylase inhibitory effects of phenoxy chalcones and molecular modeling studies.
    Kurşun-Aktar BS; Adem Ş; Tatar-Yilmaz G; Hameed ZAH; Oruç-Emre EE
    J Mol Recognit; 2023 Nov; 36(11):e3061. PubMed ID: 37720970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemic Efficacy of Docking Selected Natural Compounds against α-Glucosidase and α-Amylase.
    Riyaphan J; Jhong CH; Lin SR; Chang CH; Tsai MJ; Lee DN; Sung PJ; Leong MK; Weng CF
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30189596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
    Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes.
    Riyaphan J; Pham DC; Leong MK; Weng CF
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic potential of Catechu via assays for α-glucosidase, α-amylase, and glucose uptake in adipocytes.
    Zhang K; Chen XL; Zhao X; Ni JY; Wang HL; Han M; Zhang YM
    J Ethnopharmacol; 2022 Jun; 291():115118. PubMed ID: 35202712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors.
    Aguila-Muñoz DG; Vázquez-Lira G; Sarmiento-Tlale E; Cruz-López MC; Jiménez-Montejo FE; López Y López VE; Escalante CH; Andrade-Pavón D; Gómez-García O; Tamariz J; Mendieta-Moctezuma A
    Molecules; 2023 May; 28(10):. PubMed ID: 37241920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening.
    Thakral S; Singh V
    Med Chem; 2019; 15(2):186-195. PubMed ID: 30251608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes.
    Trinh BTD; Staerk D; Jäger AK
    J Ethnopharmacol; 2016 Jun; 186():189-195. PubMed ID: 27041401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.